NPPB and cancer: After adjusting for potential confounders, and in contrast to cancer‐specific mortality, the other‐cause mortality risk between elevated and normal NT‐proBNP remained significant in normal‐weight individuals (HR = 2.27; 95%CI = 1.81, 2.85; p < 0.001) but was no longer significant for obese individuals (HR = 0.93, 95%CI = 0.73, 1.18; p = 0.55); however, the difference in NT‐proBNP‐associated other‐cause mortality risks between normal‐weight and obese individuals remained significant (interaction HR = 0.52; 95%CI = 0.36, 0.77; p = 0.001) (Figure 1).